PFE241220C18000
- 7.70
- 0.000.00%
Pfizer Newsroom
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $27
Pfizer (PFE) Gets a Hold From Wells Fargo
Pfizer Options Spot-On: On December 16th, 205.72K Contracts Were Traded, With 3.69 Million Open Interest
Sangamo Surges 24% After Roche Ends Development of Hemophilia A Gene Therapy
Insurer Stocks Tumble. Trump Echoes Drug Industry Attacks on PBMs. -- Barrons.com
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Express News | Trump: 'We're Going to Knock Out the Middlemen' Who Are Keeping Drug Prices High
Express News | Trump: Does Not Like Mandates for Vaccines, When Asked Whether Schools Should Mandate
Express News | Trump: I'm a Big Believer in Polio Vaccine
Another Week, Another Index Record | Lkive Stock
Goldman Sachs Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Jefferies Sticks to Their Buy Rating for Pfizer (PFE)
Wells Fargo Adjusts Price Target on Pfizer to $27 From $30
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
Promise Bio Emerges From Stealth With $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases
SA Asks: How Should Investors Position Portfolios Ahead of Fed Vote?
Is Pfizer a Millionaire Maker?
Recent Dividend Declarations
Pfizer Options Spot-On: On December 13th, 131.21K Contracts Were Traded, With 3.68 Million Open Interest